Albireo Pharma, Inc.
ALBO · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$34,030 | -$107,633 | -$62,717 | -$46,111 |
| Dep. & Amort. | $274 | $192 | $127 | $45 |
| Deferred Tax | -$92,964 | -$14,573 | $4,006 | $4,617 |
| Stock-Based Comp. | $15,931 | $14,615 | $7,578 | $5,546 |
| Change in WC | -$9,681 | -$4,656 | -$10,273 | $2,126 |
| Other Non-Cash | $12,911 | $11,026 | $8,360 | $6,975 |
| Operating Cash Flow | -$107,559 | -$101,029 | -$52,919 | -$26,802 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$465 | -$78 | -$540 | -$61 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $103,387 | $0 | $0 | $14 |
| Investing Cash Flow | $102,922 | -$78 | -$540 | -$47 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $241 | $193,265 | $20,775 | $94,150 |
| Stock Repurch. | -$230 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,759 | $220,276 | $23,504 | $139,182 |
| Financing Cash Flow | $2,759 | $220,276 | $23,504 | $139,182 |
| Forex Effect | -$1,287 | $260 | -$2,087 | -$1,679 |
| Net Chg. in Cash | -$3,165 | $119,429 | -$32,042 | $110,654 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $251,272 | $131,843 | $163,885 | $53,231 |
| End Cash | $248,107 | $251,272 | $131,843 | $163,885 |
| Free Cash Flow | -$108,024 | -$101,107 | -$53,459 | -$26,863 |